Drawing for MELETIOS

USPTO serial 79324895

MELETIOS

Reviewed by CopyMark Law Group

Reg. 6914961Status 700Registered
Filing date
Status date
Registration date
Dec 6, 2022
Examiner
TRUSILO, KELLY JEAN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MELETIOS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lisa C. Pavento

Lisa C. Pavento Meunier Carlin & Curfman LLC999 Peachtree Street NESuite 1300Atlanta, GA 30309

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations, namely, anti virals and antibacterials; medical preparations for the treatment of viral and bacterial diseases; Medicines for treating viral and bacterial infectionsACTIVE—
010medical diagnostic apparatus for testing for viruses and infectionsACTIVE—
042Medical and pharmacological research services; development of pharmaceutical products; scientific research in the nature of conducting clinical trials for third parties; research and development for the pharmaceutical industry; research in the field of pharmaceutical products; pharmaceutical research and development; provision of information in connection with medical and scientific research in the field of pharmaceutical products and clinical trialsACTIVE—
044Health care services for human beings; medical information; medical services; pharmaceutical advice; information services concerning pharmaceutical products; information services relating to medicines; advisory services regarding pharmaceutical productsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 19, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 24, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 24, 2023FIMPFINAL DISPOSITION PROCESSED—
Mar 6, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 6, 2022NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Dec 6, 2022R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 27, 2022GPNXNOTIFICATION PROCESSED BY IB—
Sep 20, 2022NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 20, 2022PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 7, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 7, 2022OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Aug 31, 2022NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 16, 2022CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 22, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 21, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 21, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 6, 2022RFNTREFUSAL PROCESSED BY IB—
May 13, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 12, 2022RFRRREFUSAL PROCESSED BY MPU—
Mar 31, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 30, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 28, 2022DOCKASSIGNED TO EXAMINER—
Nov 13, 2021MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 9, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 8, 2021LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Nov 4, 2021REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance